# The key ingredient in weight loss drugs Ozempic and Wegovy reportedly reduces the risk of death from COVID-19, according to a report featured on the International Business Times. # The study found that the ingredient, semaglutide, may offer potential benefits in reducing the severity of COVID-19 and the risk of death among infected individuals. # Semaglutide is a glucagon-like peptide-1 receptor agonist, which is known for promoting weight loss and controlling blood sugar levels. # The potential link between semaglutide and a reduced risk of COVID-19 complications could be groundbreaking for individuals looking to manage their weight and overall health during the pandemic. ## **Hot Take** This new report suggesting that the key ingredient in weight loss drugs like Ozempic and Wegovy may reduce the risk of COVID-19 death is promising news for those looking to enhance their health and well-being. The potential benefits of semaglutide in not only aiding weight loss but also potentially mitigating the severity of COVID-19 highlight the importance of maintaining a healthy weight and lifestyle. For individuals seeking support in their weight loss journey, exploring options like telehealth services through Mindful Evolution could offer valuable guidance and assistance. Contact Mindful Evolution today for personalized strategies and support in achieving your weight loss goals. **Weight Loss Disclaimer:** *Individual results may vary. Consult with a healthcare provider before starting any weight loss program.* ### **Contact Mindful Evolution at [https://yourmindfulevolution.com](https://yourmindfulevolution.com) or call/text 954-639-9960 for telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.*